Services and Capabilities
Applying diverse computational and cheminformatics approaches to facilitate molecular design
Our team employs diverse computational- and cheminformatics-based approaches to facilitate drug discovery. We utilize both structure (target) and ligand-based design that relies on configuration sampling, virtual screening, and simulation. These techniques employ molecular and quantum mechanics (QM and QM/MM) to discover new leads and scaffolds for medicinal chemistry studies.
Parallelized computational chemistry and informatics (multivariate statistics and artificial intelligence) facilitates the analysis of integrated high-throughput and computational screening data to augment both hit discovery and SAR by catalog. We use our high-throughput docking/free energy scoring system to evaluate hundreds of thousands of compounds every week, allowing us to identify the best compounds for pharmacological assays.
Meet the Experts
View All Experts
Navigate to
Mark Nelms
Mark Nelms
Navigate to
Shannon Bell
Shannon Bell
Navigate to
Imari Walker-Franklin
Imari Walker-Franklin
Navigate to
Reshan Fernando
Reshan Fernando
Navigate to
Danni Harris
Danni Harris
Navigate to
Wayne Mascarella
Wayne Mascarella
Related Projects
Mapping the Kappa Opioid Receptor Using RTI's JDTic Compound
New insights enable structure-based discovery of new drugs
Read More about Mapping the Kappa Opioid Receptor Using RTI's JDTic Compound
